You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lanreotide

Showing 1 - 25 of 119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)

Recruiting
  • Paraganglioma
  • Pheochromocytoma
  • Lanreotide
  • New York, New York
  • +1 more
Oct 5, 2022

Neuroendocrine Tumors Trial in Seoul (Lanreotide autogel)

Recruiting
  • Neuroendocrine Tumors
  • Lanreotide autogel
  • Seoul, Korea, Republic of
    Changhoon Yoo
Jul 18, 2022

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Lanreotide
  • Y-90 microspheres
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Gastroenteropancreatic Neuroendocrine Tumor Trial in China (Lanreotide autogel)

Completed
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Lanreotide autogel
  • Sichuan, Chengdu, China
  • +13 more
Jan 16, 2023

Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

Terminated
Has Results
  • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
  • lanreotide
  • Placebo
  • Bruxelles, Belgium
  • +23 more
Dec 21, 2022

Neuroendocrine Tumors Trial in United States (Octreotide, LAR Lanreotide, Questionnaires)

Active, not recruiting
  • Neuroendocrine Tumors
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2022

Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)

Terminated
Has Results
  • Acromegaly
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 12, 2022

Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)

Recruiting
  • Metastatic Well Differentiated Neuroendocrine Neoplasm
  • Neuroendocrine Tumors
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021

Neuroendocrine Tumors,Gastroenteropancreatic Trial in Taipei (Cabozantinib, Lanreotide)

Not yet recruiting
  • Neuroendocrine Tumors,Gastroenteropancreatic
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 9, 2021

(RWS) of Lanreotide Autogel for Treatment of Acromegaly in China

Recruiting
  • Acromegaly
    • Beijing, China
    • +11 more
    Jul 13, 2022

    Carcinoid Syndrome Trial in Worldwide (Lanreotide, Placebo)

    Completed
    Has Results
    • Carcinoid Syndrome
    • Lanreotide
    • Placebo
    • Los Angeles, California
    • +53 more
    Sep 15, 2022

    Acromegaly: A Pattern of Treatment and Comparative Effectiveness

    Recruiting
    • Acromegaly
    • Transnasal butterfly surgery
    • +2 more
    • Guangzhou, Guangdong, China
      China Acromegaly Organization
    Mar 14, 2022

    Neuroendocrine Tumors Trial in Milan (Lanreotide and Metformin)

    Active, not recruiting
    • Neuroendocrine Tumors
    • Lanreotide and Metformin
    • Milan, Italy
      NationalCIMilan
    Jun 4, 2021

    Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

    Active, not recruiting
    • Carcinoid Tumors
    • Boston, Massachusetts
    • +1 more
    Apr 14, 2022

    Gastrointestinal Motility Disorder, Intestinal Disease Trial in New Hyde Park, New York (Lanreotide)

    Completed
    Has Results
    • Gastrointestinal Motility Disorder
    • Intestinal Disease
    • Lanreotide
    • New Hyde Park, New York
    • +1 more
    Dec 23, 2020

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)

    Not yet recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Somatostatin analog
    • Brasschaat, Antwerp, Belgium
    • +19 more
    Jan 31, 2023

    Acromegaly Trial in Santa Monica (lanreotide)

    Terminated
    Has Results
    • Acromegaly
    • lanreotide
    • Santa Monica, California
      Brain Tumor Center and Pituitary Disorders Program, John Wayne C
    Sep 2, 2021

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    Perception of Information and Quality of Life in Neuroendocrine

    Completed
    • Neuroendocrine Tumors
    • Data collection
    • Paris, France
      Ipsen Central Contact
    Aug 27, 2020

    Pancreatic Tumours, Midgut Neuroendocrine Tumours Trial in Worldwide (Lanreotide autogel 120 mg)

    Completed
    Has Results
    • Pancreatic Tumours
    • Midgut Neuroendocrine Tumours
    • Lanreotide autogel 120 mg
    • Bruxelles, Belgium
    • +31 more
    Dec 4, 2020

    Predict Lanreotide-induced Disease Activity Normalization in

    Withdrawn
    • Acromegaly
      • (no location specified)
      Jun 1, 2020

      Neuroendocrine Tumours Trial in Italy (Lanreotide (Autogel formulation) and Temozolomide)

      Completed
      Has Results
      • Neuroendocrine Tumours
      • Lanreotide (Autogel formulation) and Temozolomide
      • Viagrande, Catania, Italy
      • +9 more
      Sep 9, 2020

      Pancreatic Neuroendocrine Tumours in Routine Clinical Practice.

      Terminated
      • Pancreatic Neuroendocrine Tumor
        • Coimbra, Portugal
        • +45 more
        Jun 9, 2021

        Neuroendocrine Tumours Trial in Spain (lanreotide (Autogel formulation))

        Completed
        • Neuroendocrine Tumours
        • lanreotide (Autogel formulation)
        • A Coruña, Spain
        • +26 more
        Nov 4, 2020

        Lanreotide Autogel® 120 mg in Locally Advanced or Metastatic

        Withdrawn
        • Neuroendocrine Tumors
          • Gdańsk, Poland
          • +10 more
          Nov 4, 2020